KavaPlex 50c
Couldn't load pickup availability
Description:
Relief from mild anxiety and sleeplessness
BioMedica CalmSleep is a unique herbal blend designed to calm mild anxiety and induce sleep, offering a natural solution for those experiencing sleeplessness where pain is a feature. This practitioner-grade formulation includes standardized Kava extract, a clinically relevant dose of kavalactones, along with traditional herbs like Passiflora incarnata. Lavender and valerian are excluded, making CalmSleep a clean and effective option for stress relief and sleep induction.
To learn more about the calming properties of Kava, one of the key ingredients in this product, visit our article: Discover Kava: Pacific Calm in a Cup.
Highlights:
- Unique herbal blend to calm mild anxiety and induce sleep.
- Kava extract standardized to a clinically relevant dose of kavalactones.
- Indicated for sleeplessness where pain is a feature.
- Lavender and valerian free.
- Convenient vegetarian capsule for flexible dosing.
- Low excipient and vegan.
Dose:
Adults take 1-2 capsules daily with water.
Ingredients:
| Ingredient | Amount / Concentration | Equivalent Amount / Notes |
|---|---|---|
| Each tablet contains: | ||
| Piper methysticum root (Dry Herb Equiv) | 200 mg | |
| Equivalent Kavalactones | 60 mg | |
| Passiflora incarnata herb top flowering (Dry Herb Equiv) | 20 mg |
Excipients:
Acacia, Calcium hydrogen phosphate dihydrate, Carrageenan, Colloidal anhydrous silica, Hypromellose, Oryza sativa, Potassium acetate, Purified water, Sunflower Oil.
Allergen Information:
Free from: Dairy, Wheat, Yeast, Egg, Soy, Lactose, Glucose, Sucrose, Fructose, Sulphates/Sulphites, Gelatin, Crustaceans, Peanuts, Salicylates, Amines, Potato.
Dose:
Adults take 1-2 capsules daily with water.
Warnings:
- Do not use if pregnant or likely to become pregnant.
- Not for prolonged use.
- In rare cases, Kava has been linked to liver damage; to be prescribed under close supervision.
- Contraindicated in patients taking L-dopa and antiparkinson drugs.
- Caution is advised in patients taking central nervous system depressants.
- Discontinue 7 days prior to general anesthesia.
- If symptoms persist, seek additional professional advice.
